荧光增白剂
Search documents
华软科技跌2.05%,成交额1.91亿元,主力资金净流入3639.33万元
Xin Lang Zheng Quan· 2025-12-02 01:39
12月2日,华软科技盘中下跌2.05%,截至09:35,报6.69元/股,成交1.91亿元,换手率4.67%,总市值 54.35亿元。 资金流向方面,主力资金净流入3639.33万元,特大单买入5647.66万元,占比29.63%,卖出1894.07万 元,占比9.94%;大单买入3254.37万元,占比17.07%,卖出3368.63万元,占比17.67%。 华软科技今年以来股价涨32.48%,近5个交易日跌16.69%,近20日涨0.00%,近60日涨9.14%。 今年以来华软科技已经6次登上龙虎榜,最近一次登上龙虎榜为12月1日,当日龙虎榜净买入-1270.83万 元;买入总计1764.35万元 ,占总成交额比11.24%;卖出总计3035.18万元 ,占总成交额比19.34%。 资料显示,金陵华软科技股份有限公司位于北京市海淀区东升科技园北街2号院1号楼7层,成立日期 1999年1月13日,上市日期2010年7月20日,公司主营业务涉及计算机软硬件生产、销售。主营业务收入 构成为:AKD系列造纸化学品51.95%,医药、农药中间体17.24%,荧光增白剂16.65%,电子化学品 9.30%,其他4.8 ...
华软科技11月17日获融资买入1964.59万元,融资余额2.61亿元
Xin Lang Cai Jing· 2025-11-18 01:28
Group 1 - The core viewpoint of the news is that Huasoft Technology has experienced significant changes in its financing and operational performance, with a notable decline in revenue and net profit [1][2]. - On November 17, Huasoft Technology's stock rose by 0.27%, with a trading volume of 360 million yuan. The financing buy-in amount was 19.65 million yuan, while the financing repayment was 37.68 million yuan, resulting in a net financing outflow of 18.04 million yuan [1]. - As of November 17, the total margin balance for Huasoft Technology was 261 million yuan, accounting for 5.50% of its market capitalization, indicating a high level of financing activity compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for Huasoft Technology increased to 74,800, a rise of 67.77%, while the average circulating shares per person decreased by 40.40% to 8,191 shares [2]. - For the period from January to September 2025, Huasoft Technology reported a revenue of 261 million yuan, a year-on-year decrease of 38.93%, and a net profit attributable to the parent company of -12.5 million yuan, down 34.77% year-on-year [2]. - The company has cumulatively distributed 117 million yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3].
华软科技11月11日获融资买入1946.69万元,融资余额2.72亿元
Xin Lang Cai Jing· 2025-11-12 01:37
Group 1 - The core viewpoint of the news is that Huasoft Technology has experienced fluctuations in its financing activities and financial performance, indicating potential challenges in its business operations [1][2]. Group 2 - On November 11, Huasoft Technology's stock rose by 0.73%, with a trading volume of 222 million yuan. The financing buy-in amount was 19.47 million yuan, while the financing repayment was 20.08 million yuan, resulting in a net financing outflow of 0.61 million yuan [1]. - As of November 11, the total balance of margin trading for Huasoft Technology was 273 million yuan, with a financing balance of 272 million yuan, accounting for 6.15% of the circulating market value, which is above the 90th percentile level over the past year [1]. - The company had a margin repayment of 2,300 shares on November 11, with no shares sold short, resulting in a short balance of 32,890 yuan, which is above the 60th percentile level over the past year [1]. Group 3 - As of September 30, the number of shareholders for Huasoft Technology was 74,800, an increase of 67.77% compared to the previous period. The average circulating shares per person decreased by 40.40% to 8,191 shares [2]. - For the period from January to September 2025, Huasoft Technology reported operating revenue of 261 million yuan, a year-on-year decrease of 38.93%. The net profit attributable to the parent company was -125 million yuan, a year-on-year decrease of 34.77% [2]. Group 4 - Since its A-share listing, Huasoft Technology has distributed a total of 117 million yuan in dividends, with no dividends distributed in the past three years [3].
华软科技涨2.05%,成交额2.15亿元,主力资金净流入345.89万元
Xin Lang Zheng Quan· 2025-10-21 06:00
Group 1 - The core viewpoint of the news is that Huasoft Technology has shown a significant stock price increase of 38.02% year-to-date, despite a recent slight decline in the last five trading days [1] - As of October 21, the stock price reached 6.97 yuan per share, with a market capitalization of 5.662 billion yuan and a trading volume of 215 million yuan [1] - The company has experienced net inflows of main funds amounting to 3.4589 million yuan, with large orders contributing significantly to the buying activity [1] Group 2 - Huasoft Technology's main business revenue composition includes 51.95% from AKD series paper chemicals, 17.24% from pharmaceutical and pesticide intermediates, 16.65% from fluorescent whitening agents, and 9.30% from electronic chemicals [1] - The company belongs to the basic chemical industry, specifically in the category of chemical products, and is involved in sectors such as photolithography, semiconductors, and electronic chemicals [2] - As of June 30, the number of shareholders increased by 10.26% to 44,600, while the average circulating shares per person decreased by 9.03% [2] Group 3 - Since its A-share listing, Huasoft Technology has distributed a total of 117 million yuan in dividends, with no dividends paid in the last three years [3]
华软科技9月30日获融资买入9172.27万元,融资余额2.92亿元
Xin Lang Cai Jing· 2025-10-09 01:26
Group 1 - The core viewpoint of the news is that Huasoft Technology experienced a significant decline in stock price and trading volume on September 30, with a drop of 9.75% and a trading volume of 1.185 billion yuan [1] - On September 30, Huasoft Technology had a financing buy-in amount of 91.72 million yuan and a net financing buy-in of 27.58 million yuan, indicating strong investor interest despite the stock price drop [1] - The total financing and securities lending balance for Huasoft Technology reached 292 million yuan, which is 6.36% of its circulating market value, indicating a high level of leverage [1] Group 2 - As of June 30, Huasoft Technology had 44,600 shareholders, an increase of 10.26% from the previous period, while the average circulating shares per person decreased by 9.03% to 13,743 shares [2] - For the first half of 2025, Huasoft Technology reported an operating income of 171 million yuan, a year-on-year decrease of 31.63%, and a net profit attributable to shareholders of -91.59 million yuan, a decline of 53.21% [2] - Since its A-share listing, Huasoft Technology has distributed a total of 117 million yuan in dividends, with no dividends paid in the last three years [3]
“4连板”华软科技回应 光刻胶相关产品收入占比低
Zheng Quan Shi Bao· 2025-09-24 17:59
Core Viewpoint - Huasoft Technology (002453) has experienced a significant increase in stock price due to heightened market interest in the "photoresist" concept, despite the company's limited revenue contribution from related products [1][2]. Group 1: Company Overview - Huasoft Technology's main business focuses on the research, production, and sales of fine chemical products, including paper chemicals, pharmaceutical/agricultural intermediates, fluorescent whitening agents, and electronic chemicals [1]. - The revenue from electronic chemicals is projected to account for less than 6% of the company's total revenue in 2024 [1]. Group 2: Photoresist Business - The company currently produces photo initiator products in small batches based on customer orders, with revenue from these products expected to contribute less than 2% to total revenue in 2024 [1]. - The impact of the photoresist business on the company's overall performance has been minimal for the past two years, and future sales are subject to significant uncertainty due to various influencing factors [1]. Group 3: Market Response - On September 24, Huasoft Technology's stock price rose by 10%, reaching a new high since January 2024, with over 330,000 shares traded at the close [1]. - The company's electronic chemicals business reported revenue of 15.88 million yuan in the first half of 2025, accounting for 9.3% of total revenue, while the 2024 revenue was 30.11 million yuan, representing 5.84% of total revenue [2].
4连板华软科技回应“光刻胶概念” 相关产品收入占比较低
Zheng Quan Shi Bao Wang· 2025-09-24 13:02
Core Viewpoint - Huasoft Technology (002453) has experienced a significant stock price increase, attributed to heightened market interest in its involvement with the "photoresist" concept, despite the company's limited revenue contribution from this segment [1][2]. Group 1: Company Overview - Huasoft Technology's main business focuses on the research, production, and sales of fine chemical products, including paper chemicals, pharmaceutical/agricultural intermediates, fluorescent whitening agents, and electronic chemicals [1]. - The electronic chemicals segment is projected to contribute less than 6% to the company's total revenue in 2024 [1]. - The company's existing photoresist products, specifically photoinitiators, are produced in small batches based on customer orders, with revenue from this segment expected to be less than 2% of total revenue in 2024 [1]. Group 2: Market Performance - On September 24, Huasoft Technology's stock price rose by 10%, reaching a new high since January 2024, with over 330,000 shares traded by the end of the day [2]. - As of June 30, 2023, Huasoft Technology had approximately 44,600 shareholders [2]. Group 3: Product Details - Huasoft Technology's electronic chemicals include ML-8, which is a key raw material for coatings used in displays for mobile phones, computers, and televisions, enhancing performance while reducing energy consumption [2]. - The company's electronic chemicals generated revenue of 15.88 million yuan in the first half of 2025, accounting for 9.3% of total revenue, while the projected revenue for 2024 is 30.11 million yuan, representing 5.84% of total revenue [2].
四连板华软科技:现有光引发剂产品按客户订单小批量生产销售 2024年收入占比约不到2%
Xin Lang Cai Jing· 2025-09-24 11:02
Core Viewpoint - Huasoft Technology (002453.SZ) has announced that its existing photoinitiator products are being produced and sold in small batches based on customer orders, with revenue from these products expected to account for less than 2% of total revenue in 2024, indicating a limited impact on the company's overall performance in the near term [1] Company Overview - Huasoft Technology's main business focuses on the research, development, production, and sales of fine chemical products, including paper chemicals, pharmaceutical/agricultural intermediates, fluorescent whitening agents, and electronic chemicals [1] - The electronic chemicals segment is projected to contribute less than 6% to the company's total revenue in 2024 [1] Revenue Impact - The revenue from the existing photoinitiator products is anticipated to be minimal, with an estimated contribution of less than 2% to total revenue in 2024, reflecting a consistent trend over the past two years where the impact on operational performance has been minor [1] - Future sales of the photoinitiator products are subject to significant uncertainty due to various influencing factors [1]
4连板华软科技:现有光引发剂产品按客户订单小批量生产销售 2024年收入占比约不到2%
Ge Long Hui A P P· 2025-09-24 11:02
Group 1 - The company, Huasoft Technology (002453.SZ), has announced unusual fluctuations in its stock trading, noting increased market attention on the "photoresist" concept [1] - The company's main business involves the research, production, and sales of fine chemical products, including paper chemicals, pharmaceutical/agricultural intermediates, fluorescent whitening agents, and electronic chemicals [1] - Electronic chemicals are projected to account for less than 6% of the company's total revenue in 2024 [1] Group 2 - Regarding the photoresist substrate business, the company currently produces photoinitiator products in small batches based on customer orders [1] - Revenue from these photoinitiator products is expected to represent about 2% of the company's total revenue in 2024, indicating a minimal impact on the company's operating performance over the past two years [1] - Future sales of these products are subject to significant uncertainty due to various influencing factors [1]
华软科技:现有光引发剂产品按客户订单小批量生产销售 收入占比较小
Zheng Quan Shi Bao Wang· 2025-09-24 11:01
Core Viewpoint - The company, Huasoft Technology, has noted increased market attention on the "photoresist" concept, although its current revenue from related products is minimal and subject to uncertainty [1] Group 1: Company Overview - Huasoft Technology's main business involves the research, production, and sales of fine chemical products, including paper chemicals, pharmaceutical/pesticide intermediates, fluorescent whitening agents, and electronic chemicals [1] - Electronic chemicals are projected to account for less than 6% of the company's total revenue in 2024 [1] Group 2: Photoresist Business - The company currently produces photo-initiator products for photoresist applications, which are sold in small batches based on customer orders [1] - Revenue from photoresist products is expected to contribute less than 2% to the company's total revenue in 2024, indicating a minimal impact on overall business performance for two consecutive years [1] - Future sales of photoresist products are subject to significant uncertainty due to various influencing factors [1]